Skip to main navigation
Skip to search
Skip to main content
Monash University Home
Help & FAQ
Home
Profiles
Research units
Equipment
Projects
Outputs
Prizes
Activities
Press/Media
Search by expertise, name or affiliation
A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy and safety of 4 oral doses of BI 1358894 once daily over 12 week treatment period in patients with borderline personality disorder.
Chen, Leo
(Primary Chief Investigator (PCI))
De Castella, Anthony
(Project Manager)
Department of Psychiatry (STM)
Project
:
Research
Overview
Project Details
Status
Finished
Effective start/end date
1/12/20
→
31/12/23
View all
View less
Keywords
Psychiatry
Borderline Personality Disorder
Clinical trial